Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its
more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver …

Steady progress over four decades toward understanding the pathogenesis and clinical
consequences of hepatic fibrosis has led to the expectation of effective antifibrotic drugs, yet …

Big data in health care is a fast-growing field and a new paradigm that is transforming case-
based studies to large-scale, data-driven research. As big data is dependent on the …

There has been a rise in the prevalence of nonalcoholic fatty liver disease (NAFLD),
paralleling a worldwide increase in diabetes and metabolic syndrome. NAFLD, a continuum …

The diagnostic assessment of liver injury is an important step in the management of patients
with chronic liver disease (CLD). Although liver biopsy is the reference standard for the …

Large information analytics can improve affected person outcomes, enhance and customise
care, enhance company collaborations with treatment holders and deduction the huge cost …

Precision public health is an emerging practice to more granularly predict and understand
public health risks and customize treatments for more specific and homogeneous …

Hepatocellular carcinoma (HCC) is the most common form of primary adult liver cancer. After
nearly a decade with sorafenib as the only approved treatment, multiple new agents have …

Big data methodologies, made possible with the increasing generation and availability of
digital data and enhanced analytical capabilities, have produced new insights to improve …

The advancement of investigation tools and electronic health records (EHR) enables a
paradigm shift from guideline‐specific therapy toward patient‐specific precision medicine …